SCHEMBL30150591

SCHEMBL30150591

CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 6/20 0.51
▸ CTSD P07339 3/20 0.51
▸ CALCRL Q16602 4/20 0.45
▸ KDM1A O60341 3/20 0.45
▸ MAOB P27338 1/20 0.45
▸ KDM5A P29375 1/20 0.45
▸ KDM1B Q8NB78 1/20 0.45
▸ EP300 Q09472 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ F2 P00734 2/20 0.41
▸ XIAP P98170 1/20 0.41
▸ GRB2 P62993 1/20 0.41
▸ NPY1R P25929 1/20 0.41
▸ NPY2R P49146 1/20 0.41
▸ NPY4R P50391 1/20 0.41
▸ NPY5R Q15761 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30150556 0.96 BACE1 (0.49) BACE1CTSDCALCRLKDM1AMAOB
SCHEMBL29641620 0.94 KDM1A (0.45) BACE1CTSDCALCRLKDM1AMAOB
SCHEMBL30495673 0.91 BACE1 (0.49) BACE1CTSDCALCRLKDM1AMAOB
SCHEMBL30150576 0.90 CALCRL (0.47) BACE1CTSDCALCRLF2XIAP
SCHEMBL30512575 0.90 NPY2R (0.49) KDM1AMAOBKDM5AKDM1BEP300
SCHEMBL31182552 0.90 BACE1 (0.47) BACE1CTSDCALCRLEP300HIF1A
SCHEMBL29727004 0.89 AGTR2 (0.47) BACE1CTSDCALCRLEP300HIF1A
SCHEMBL29727005 0.89 AGTR2 (0.47) BACE1CTSDCALCRLEP300HIF1A
SCHEMBL29733250 0.86 CALCRL (0.47) BACE1CTSDCALCRLXIAP
SCHEMBL29379577 0.86 GRB2 (0.50) BACE1CTSDXIAPGRB2NPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220409709-A1 LABYRINTHIN-BASED PEPTIDES FOR CANCER IMMUNOTHERAPIES AND USES THEREOF LABYRX IMMUNOLOGIC THERAPEUTICS USA LTD (US) 2022-12-29 — — US disclosed
Send feedback